Cutting Edge: FcgRIII (CD16) and FcgRI (CD64) Are Responsible for Anti-Glycoprotein 75 Monoclonal Antibody TA99 Therapy for Experimental Metastatic B16 Melanoma
2 Marzo 2022 0
Marcello Albanesi,*,† David A. Mancardi,*,† Lynn E. Macdonald,‡ Bruno Iannascoli,*,† Laurence Zitvogel, x,{Andrew J. Murphy,‡Jeanette H. Leusen,‖ and Pierre Bruhns*,†
